medigraphic.com
SPANISH

Revista Archivo Médico de Camagüey

ISSN 1025-0255 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 5

<< Back Next >>

AMC 2018; 22 (5)

Use of intrapleural recombinant streptokinase in a pregnant woman with pleural empyema

García RME, Martínez PY, Morales RRA, Ramírez RE, Benavides MA, Chávez CM
Full text How to cite this article

Language: Spanish
References: 0
Page: 767-780
PDF size: 466.17 Kb.


Key words:

No keywords

ABSTRACT

Background: pneumonia complicates 0,78-2,7 per 1 000 pregnancies placing the mother and the fetus at risk. Empyema as a complication of pneumonia in a pregnant patient adds a high rate of morbidity and mortality to the mother and the fetus if one does not act quickly.
Objective: to present the case of a pregnant woman of 33 weeks who developed a pleural empyema resulting from acquired pneumonia.
Clinical case: 33-week gestated patient, asthmatic admitted to the intensive care unit of the University Hospital Manuel Ascunce Domenech with the diagnosis of severe pneumonia acquired in the community complicated with para-pneumonic effusion, which evolved into empyema. It was treated with a thoracotomy tube and fibrinolytic therapy, with good clinical and radiological evolution.
Conclusions: Recombinant streptokinase can be used safely and effectively for the management of PE, as an intrapleural fibrinolytic agent, during pregnancy.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

AMC. 2018;22